NVIDIA and Cadence are collaborating to transform data center design and operations and accelerate drug discovery.
See how NVIDIA and Cadence are improving data center performance and energy efficiency and accelerating drug discovery.
Cadence now integrates NVIDIA NeMo™ and NIM™ microservices, part of the NVIDIA AI Enterprise software platform, into all their generative AI applications.
See how NVIDIA teams bring up our AI factories faster than ever with Omniverse digital twins and our ecosystem of partners including Cadence, Motivair, Schneider Electric, and Vertiv.
NVIDIA Omniverse Cloud will be available as APIs, extending the reach of the world’s leading platform for creating industrial digital twins across the entire ecosystem of software makers.
Cadence Systems, which owns OpenEye’s Orion molecular design platform for accelerating drug discovery, is integrating NVIDIA BioNeMo microservices to accelerate drug discovery.
Cadence will use Blackwell-based processors to accelerate their software for designing and simulating electrical, mechanical, and manufacturing systems and parts.
Cadence is adopting new enterprise-grade generative AI microservices to improve data center efficiency and accelerate drug discovery.